This application claims priority on, and incorporates by reference, United States Provisional Application Ser. No. 60/160,029 filed Oct. 18, 1999.
The work described herein was supported by U.S. Army Grant number DAMD 17-96-1-6077 and NH & MRC 950215 and NH & MRC 973769.
Entry |
---|
Mick, R. et al, Clinical Pharmacology and Therapeutics, 1994 56, 2, 217-222.* |
Efron, B. et al, Proceedings of the National Academy of Sciences of the United States of America, 1996, 93, 23, 13429-13434.* |
D'Amico, A. et al, Cancer 1998, 82, 10, 1887-1896.* |
Berweger, C. D. et al, Clinica Chimica Acta 1998, 277, 107-125.* |
Mountford C. E. et al, Science 1984, 226, 1415-1418.* |
Klein, P. et al, Journal of THeoretical Biology 1988, 130, 461-468.* |
Grahn, H. F. et al, Chemometrics and Intelligent Laboratory Systems 1992, 14, 391-396.* |
Hanaoka, H. et al, Magnetic Resonance in Medicine 1993, 29, 436-440.* |
Florian, C. L. et al, NMR in Biomedicine 1995, 8, 253-264.* |
Kitchen PR, McLennan R, Mursell A. Node-positive breast cancer: a comparison of clinical and pathological findings and assessment of axillary clearance. Australian & New Zealand Journal of Surgery 1980; 50: 580-3.* |
Dixon JM, Senbanjo RO, Anderson TJ, mammography. Risk of breast cancer based on age and mammographic interpretation Clinical Oncology 1984; 10: 117-21.* |
Kerlikowske K, Grady D, Barclay J. Sickles EA, Ernster V. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. [JAMA 1996: 276: 39-43].* |
Cohen, Jacob; Weighted Kappa; Nominal Scale Agreement With Provision For Scaled Disagreement Or Partial Credit, Psychological Bulletin vol. 70, No. 4, pp. 213-220, Oct. 1968.* |
Somorjai, R. L. et al, Magnetic Resonance in Medicine 1995, 33, 257-263.* |
Lean, C. L. et al, Journal of Clinical Endocrinology & Metabolism 1995, 80, 1306-1311.* |
Bernstein C. N. et al, Gasteroenterology 1995, 108, Suppliment, A449.* |
de Certaines, J. D. et al, Anticancer Research 1996, 16, 1451-1460.* |
Giard RW, Hermans J. The value of aspiration cytologic examination of the breast. A statistical review of the medical literature. Cancer 1992; 69:2104-10.* |
Delikatny EJ, Russell P, Hunter JC, et al. Proton MR and human cervical neoplasia: ex-vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in-situ and other preinvasive lesions. Radiology 1993; 188:791-6.* |
Lean CL, Newland RC, Ende DA, Bokey EL, Smith IC, Mountford CE. Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology. Magnetic Resonance in Medicine 1993; 30:525-33.* |
Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. American Journal of Medicine 1994; 96:383-8.* |
Rutter A, Hugenholtz H, Saunders JK, Smith IC. Classification of brain tumors by ex vivo 1H NMR spectroscopy. Journal of Neurochemistry 1995; 64:1655-61.* |
Mountford CE, Lean CL, Hancock R, et al. Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invasion & Metastasis 1993; 13:57-71.* |
Mountford C. E. et al, Anticancer Research 1996, 16, 1521-1531.* |
Bezabeh, T. et al, Anticancer Research 1996, 16, 1553-1558.* |
Somorjai, R. L. et al, Journal of Magnetic Resonance Imaging 1996, 6, 437-444.* |
MacKinnon, W. B. et al, Radiology 1997, 204, 661-666.* |
Weidner N. Prognostic factors in breast carcinoma. Current Opinion in Obstetrics & Gynecology 1995; 7:4-9.* |
Fisher B, Ravdin RG, Ausman RK, Slack NH, Moore GE, Noer RJ. Surgical adjuvant chemotherapy in cancer of the breast; results of a decade of cooperative investigation. Annals of Surgery 1968; 168:337-56.* |
Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. It is indicated? Cancer 1994; 73:664-7.* |
Chen YY, Schnitt SJ. Prognostic factors for patients with breast cancers 1cm and smaller. Breast Cancer Research & Treatment 1998; 51:209-25.* |
Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer [editorial]. Cancer 1994; 73:505-8.* |
Beechey-Newman N. Sentinel node biopsy: a revolution in the surgical management of breast cancer? Cancer Treatment Reviews 1998; 24:185-203.* |
Hill AD, Mann GB, Borgen PI, Cody HS, 3rd. Sentinel lymphatic mapping in breast cancer. Journal of the American College of Surgeons 1999; 188:545-9.* |
Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma [Cancer 1997; 79:1918-22.]* |
Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer 1994; 73:350-3.* |
Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. Journal of Clinical Oncology 1989; 7:1239-51.* |
Pinder SE, Ellis IO, Galea M, O'Rouke S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994; 24:41-7.* |
De Laurentiis M, Gallo C, De Placido S, et al. A predictive index of axillary nodal involvement in operable breast cancer. British Journal of Cancer 1996; 73:1241-7.* |
Lauria R, Perrone F, Carlomagno C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 1995; 76:1772-8.* |
Mountford, C. E. et al, Biophysical Chemistry 1997, 68, 127-135.* |
Wallace, J. C. et al, Magnetic Resonance in Medicine 1997, 38, 569-576.* |
Hahn, P. et al, Cancer Research 1997, 57, 3398-3401.* |
Hagberg, G. NMR in Biomedicine 1998 11, 148-156.* |
Nikulin, A. E. et al, NMR in Biomedicine 1998 11, 209-216.* |
Cheng, L. L. et al, Journal of Magnetic Resonance 1998, 135, 194-202.* |
Gribbestad, I. S. et al, Anticancer Research 1999, 19, 1737-1746. |
Number | Date | Country | |
---|---|---|---|
60/160029 | Oct 1999 | US |